Literature DB >> 7528235

The clinical relevance of basophil releasability.

G Marone1, G Spadaro, V Patella, A Genovese.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7528235     DOI： 10.1016/0091-6749(94)90345-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

Review 1.  Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.

Authors:  Peter Valent; Cem Akin; Patrizia Bonadonna; Karin Hartmann; Knut Brockow; Marek Niedoszytko; Boguslaw Nedoszytko; Frank Siebenhaar; Wolfgang R Sperr; Joanna N G Oude Elberink; Joseph H Butterfield; Ivan Alvarez-Twose; Karl Sotlar; Andreas Reiter; Hanneke C Kluin-Nelemans; Olivier Hermine; Jason Gotlib; Sigurd Broesby-Olsen; Alberto Orfao; Hans-Peter Horny; Massimo Triggiani; Michel Arock; Lawrence B Schwartz; Dean D Metcalfe
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-05

Review 2.  Cellular immune response parameters that influence IgE sensitization.

Authors:  Pamela A Frischmeyer-Guerrerio; John T Schroeder
Journal:  J Immunol Methods       Date:  2012-01-08       Impact factor: 2.303

3.  Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease.

Authors:  John T Schroeder; Kristin L Chichester; Anja P Bieneman
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

4.  The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils.

Authors:  Katharina Blatt; Harald Herrmann; Irina Mirkina; Emir Hadzijusufovic; Barbara Peter; Sabine Strommer; Gregor Hoermann; Matthias Mayerhofer; Konrad Hoetzenecker; Walter Klepetko; Viviane Ghanim; Katharina Marth; Thorsten Füreder; Volker Wacheck; Rudolf Valenta; Peter Valent
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

5.  BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils.

Authors:  D Smiljkovic; K Blatt; G Stefanzl; Y Dorofeeva; C Skrabs; M Focke-Tejkl; W R Sperr; U Jaeger; R Valenta; P Valent
Journal:  Allergy       Date:  2017-04-20       Impact factor: 13.146

Review 6.  Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.

Authors:  Peter Valent; Cem Akin; Boguslaw Nedoszytko; Patrizia Bonadonna; Karin Hartmann; Marek Niedoszytko; Knut Brockow; Frank Siebenhaar; Massimo Triggiani; Michel Arock; Jan Romantowski; Aleksandra Górska; Lawrence B Schwartz; Dean D Metcalfe
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

Review 7.  Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022.

Authors:  Peter Valent; Karin Hartmann; Patrizia Bonadonna; Marek Niedoszytko; Massimo Triggiani; Michel Arock; Knut Brockow
Journal:  Int Arch Allergy Immunol       Date:  2022-05-23       Impact factor: 3.767

8.  Basophil markers for identification and activation in the indirect basophil activation test by flow cytometry for diagnosis of autoimmune urticaria.

Authors:  Zehwan Kim; Bong Seok Choi; Jong Kun Kim; Dong Il Won
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.